RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Cardiotoxicity
Accession: DOID:9002371
browse the term
Definition: Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Synonyms: exact_synonym: Cardiac Toxicities; Cardiac Toxicity; Cardiotoxicities
primary_id: MESH:D066126
xref: EFO:1001482
G
ACACB
acetyl-CoA carboxylase beta
ISO
mRNA, protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
G
AGT
angiotensinogen
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33676887
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26145887
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BMP2
bone morphogenetic protein 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
G
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35792220
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL2
C-C motif chemokine ligand 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA, protein:decreased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CSF1
colony stimulating factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
G
CXCL8
C-X-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
FAS
Fas cell surface death receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:hypermethylation:promoter
RGD
PMID:35462195
RGD:329951017
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
HBEGF
heparin binding EGF like growth factor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
IL1B
interleukin 1 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
KCNN2
potassium calcium-activated channel subfamily N member 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:32909839 PMID:33887967
NCBI chr 5:114,055,978...114,496,496
Ensembl chr 5:114,055,926...114,496,500
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34648132
NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
G
MIR143
microRNA 143
ameliorates
ISO
RGD
PMID:32170053
RGD:155883163
NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
G
MIR208A
microRNA 208a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26454886
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
G
MLYCD
malonyl-CoA decarboxylase
ISO
protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr16:83,899,115...83,927,031
Ensembl chr16:83,899,115...83,951,445
G
NOS3
nitric oxide synthase 3
treatment
IAGP
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human)
RGD
PMID:26345518
RGD:11533645
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPPB
natriuretic peptide B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NRG1
neuregulin 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
ISO
protein:decreased expression:serum, heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
G
RAC1
Rac family small GTPase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28710503
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
G
RARG
retinoic acid receptor gamma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237429
NCBI chr12:53,210,569...53,232,209
Ensembl chr12:53,210,567...53,232,980
G
RNF10
ring finger protein 10
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36740146
NCBI chr12:120,534,356...120,577,588
Ensembl chr12:120,533,480...120,577,588
G
SIRT6
sirtuin 6
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34713381
NCBI chr19:4,174,109...4,182,563
Ensembl chr19:4,174,109...4,182,566
G
TLR2
toll like receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987 PMID:32068018
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30009776 PMID:34713381
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
IAGP
DNA:missense mutation:cds:p.G671V (human)
RGD
PMID:16330681
RGD:11041175
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ACVR2B
activin A receptor type 2B
treatment
IMP
human construct in mouse model
RGD
PMID:30765322
RGD:329849112
NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
G
CAPN2
calpain 2
treatment
ISO
RGD
PMID:25634181
RGD:13792617
NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
IAGP
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human)
RGD
PMID:24284041
RGD:11252190
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all